worldwid
pandem
novel
influenza
remind
us
influenza
still
lethal
diseas
acut
lung
injuri
acut
respiratori
distress
syndrom
ard
devast
complic
pathogen
present
case
previous
healthi
obes
man
succumb
ard
focus
review
discuss
pathophysiolog
peculiar
manag
acut
lung
injuryard
relat
infect
man
signific
medic
histori
hospit
complaint
short
breath
fever
nausea
bodi
ach
day
durat
symptom
preced
episod
sore
throat
cough
begin
approxim
day
current
present
receiv
cours
azithromycin
antituss
urgent
care
facil
note
patient
spous
fever
cough
week
onset
symptom
vital
sign
present
reveal
temperatur
puls
rate
per
minut
blood
pressur
mm
hg
respiratori
rate
oxygen
satur
room
air
bodi
mass
index
kgm
respiratori
examin
signific
bilater
rhonchi
occasion
expiratori
wheez
pertin
laboratori
abnorm
includ
serum
creatin
kinas
unit
normal
remaind
initi
laboratori
work
within
normal
limit
rapid
human
immunodefici
influenza
screen
neg
chest
xray
present
reveal
diffus
bilater
alveolar
opac
figur
initi
antibiot
coverag
includ
vancomycin
moxifloxacin
piperacillin
oseltamivir
weightbas
enoxaparin
use
thromboprophylaxi
respiratori
statu
deterior
within
hour
hospit
requir
intub
mechan
ventil
novel
influenza
confirm
base
posit
polymeras
chain
reaction
pcr
initi
manag
lungprotect
mechan
ventil
fluid
restrict
worsen
hypoxemia
start
intraven
peramivir
although
comput
tomographi
angiogram
thorax
show
evid
pulmonari
embol
figur
fulli
anticoagul
day
inhal
nitric
oxid
therapi
start
refractori
hypoxemia
sao
condit
continu
deterior
die
day
admiss
lung
histopatholog
postmortem
examin
reveal
diffus
alveolar
damag
dad
alveolar
hemorrhag
necrot
bronchiol
small
thromboemboli
figur
within
month
initi
outbreak
novel
influenza
mexico
late
march
world
health
organ
declar
global
pandem
influenza
underway
summer
fall
influenza
sicken
approxim
million
american
hospit
anoth
kill
younger
year
mortal
data
contrast
significantli
typic
season
influenza
overwhelm
major
death
occur
elderli
direct
term
everi
american
affect
influenza
infect
suffer
typic
flulik
symptomsfev
headach
cough
myalgiasand
selflimit
cours
howev
small
proport
patient
infect
present
rapidli
progress
lower
respiratori
tract
involv
result
respiratori
failur
develop
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
case
report
patient
describ
high
morbid
mortal
aliard
present
review
discuss
pathophysiolog
manag
aliard
relat
infect
ard
sever
manifest
ali
affect
approxim
american
year
although
mani
caus
ard
far
away
common
pneumonia
afflict
individu
requir
intub
mechan
ventil
often
week
syndrom
associ
signific
morbid
resourc
util
mortal
rate
vari
depend
patient
demograph
number
extrapulmonari
organ
failur
attempt
standard
diagnosi
ard
american
european
consensu
confer
propos
follow
definit
acut
onset
bilater
alveolar
infiltr
chest
radiograph
consist
pulmonari
edema
pao
fio
ratio
mm
hg
ard
mm
hg
ali
pulmonari
arteri
occlus
pressur
mm
hg
clinic
evid
left
atrial
hypertens
although
first
consider
american
european
consensu
confer
definit
aliard
may
seem
overli
simplist
seem
defin
reason
homogen
type
lung
injuri
patient
meet
consensu
definit
dad
autopsi
wherea
patient
dad
autopsi
met
consensu
definit
incid
ali
ard
estim
approxim
case
per
personyear
case
per
personyear
incid
found
higher
advanc
age
recent
experi
novel
influenza
estim
patient
clinic
influenza
requir
hospit
develop
respiratori
failur
report
ard
occur
associ
novel
influenza
identifi
younger
median
patient
age
histor
associ
ard
respiratori
infect
includ
season
influenza
reason
remain
unclear
incid
ali
seem
highest
patient
obes
pregnant
viru
shown
tropism
tracheal
bronchial
cell
also
type
type
pneumocyt
result
widespread
denud
epitheli
layer
consequ
rang
patholog
chang
describ
ard
includ
tracheobronchi
injuri
alveolar
hemorrhag
dad
figur
exuber
express
proinflammatori
cytokin
tumor
necrosi
disrupt
alveolar
epitheli
barrier
lead
robust
system
inflammatori
respons
associ
multipl
organ
dysfunct
ali
pattern
dad
character
hyalin
membran
format
within
alveolar
space
may
resolv
rel
minor
residu
pulmonari
impair
surviv
patient
may
initi
fibroprolif
respons
lung
protract
respiratori
failur
autopsi
evid
acut
bacteri
pneumonia
seen
fatal
case
gramposit
cocci
streptococc
staphylococc
speci
predomin
gener
initi
symptom
novel
influenza
similar
season
influenza
present
symptom
usual
includ
follow
fever
chill
cough
sore
throat
myalgia
headach
fatigu
higher
preval
diarrhea
vomit
report
outbreak
typic
seen
season
influenza
dyspnea
chest
discomfort
confus
sever
vomit
may
sign
sever
influenza
requir
hospit
earli
report
experi
mexico
observ
median
day
onset
symptom
admiss
hospit
progress
respiratori
failur
occur
usual
occur
rapidli
major
patient
requir
intub
within
hour
hospit
absenc
signific
influenza
activ
commun
influenzalik
symptom
low
specif
contrast
comput
tomographi
ct
angiogram
thorax
patient
perform
look
evid
pulmonari
embol
lung
window
demonstr
parenchym
abnorm
pulmonari
emboli
identifi
examin
although
small
segment
pulmonari
emboli
found
autopsi
influenza
contrast
influenza
epidem
patient
present
symptom
actual
influenza
import
rememb
patient
comorbid
ill
may
present
exacerb
underli
diseas
state
primari
manifest
influenza
exampl
exacerb
asthma
congest
heart
failur
acut
myocardi
infarct
associ
acut
influenza
infect
reason
threshold
suspect
influenza
low
set
epidem
rapid
influenza
screen
base
later
flow
immunodiagnost
test
rapid
flu
test
report
wide
rang
sensit
strain
limit
util
test
report
sensit
specif
revers
transcriptas
pcr
rtpcr
approach
howev
long
turnaround
time
rtpcr
result
treatment
must
initi
base
clinic
suspicion
intub
patient
initi
test
pandem
infect
consist
pair
nasopharyng
tracheal
aspir
specimen
rtpcr
sever
influenza
hematolog
biochem
test
may
reveal
leukopenia
increas
serum
lactat
dehydrogenas
creatin
kinas
uncommonli
thrombocytopenia
may
occur
chest
radiographi
may
normal
may
reveal
illdefin
patchi
airspac
diseas
larg
area
consolid
figur
hypoxemia
omin
sign
standard
contact
droplet
precaut
practic
level
health
care
emphas
respiratori
etiquett
hand
hygien
distanc
cohort
adequ
room
ventil
use
surgic
mask
close
contact
patient
respiratori
ill
patient
signific
comorbid
ill
requir
hospit
influenza
oseltamivir
recommend
firstlin
therapi
higher
dose
longer
durat
therapi
may
appropri
set
experi
date
suggest
treatment
critic
ill
patient
continu
least
day
unless
conclus
evid
viral
replic
ceas
resist
novel
influenza
oseltamivir
report
especi
immunocompromis
patient
attribut
mutat
confer
resist
oseltamivir
resist
isol
far
su
ceptibl
zanamivir
peramivir
experiment
neuraminidas
inhibitor
receiv
emerg
use
author
us
food
drug
administr
hospit
patient
avail
method
treatment
ineffect
unavail
peramivir
current
intraven
antivir
treat
novel
influenza
howev
recommend
case
oseltamivir
resist
patient
die
influenza
microbiolog
patholog
evid
secondari
pneumonia
convinc
way
exclud
bacteri
pneumonia
patient
present
pulmonari
infiltr
flulik
symptom
empir
antibiot
justifi
empir
antibiot
base
evidencebas
guidelin
communityacquir
pneumonia
caveat
communityacquir
methicillinresist
staphylococcu
aureu
pneumonia
occur
increas
frequenc
postinfluenza
period
whenev
possibl
result
microbiolog
studi
use
guid
antibiot
usag
healthcareassoci
respiratori
infect
includ
associ
invas
ventil
may
particular
signific
patient
ard
appropri
measur
prevent
appli
empir
antibiot
therapi
set
base
local
epidemiolog
although
specif
treatment
aliard
much
research
devot
optim
ventilatori
manag
patient
larg
studi
conduct
nation
institut
health
network
acut
respiratori
distress
syndrom
ardsnet
show
conclus
lungprotect
mechan
ventil
strategi
use
lowtid
volum
ventil
mlkg
predict
bodi
weight
plateau
pressur
cm
h
significantli
reduc
patient
morbid
mortal
recent
metaanalysi
reiter
benefici
effect
lowtid
volum
strategi
manag
patient
use
lowertid
volum
ventil
consid
standard
care
patient
aliard
use
explicit
standard
written
protocol
improv
physician
complianc
lungprotect
mechan
ventil
posit
endexpiratori
pressur
peep
reduc
intrapulmonari
shunt
improv
oxygen
ali
optim
level
peep
aliard
remain
controversi
advoc
use
peep
level
lower
inflect
point
lung
pressurevolum
curv
method
avoid
repetit
recruit
derecruit
alveoli
result
atelectrauma
other
suggest
titrat
peep
fio
lowest
level
compat
accept
oxygen
sever
random
control
clinic
trial
fail
demonstr
benefit
higher
level
peep
clinic
outcom
therefor
unselect
patient
aliard
current
recommend
titrat
peep
fio
target
level
oxyhemoglobin
satur
evid
becom
avail
recruit
maneuv
involv
intent
shortterm
use
high
transpulmonari
pressur
effort
open
derecruit
lung
unit
increas
endexpiratori
lung
volum
variou
maneuv
sustain
inflat
sigh
investig
although
maneuv
may
improv
oxygen
translat
surviv
benefit
basi
avail
evid
recruit
maneuv
consid
use
individu
basi
patient
aliard
lifethreaten
hypoxemia
ardsnet
low
tidal
volum
ventil
trial
perform
use
volumepreset
mechan
ventil
tidal
volum
mlkg
predict
bodi
weight
recent
signific
interest
variou
mode
pressurepreset
ventil
may
permit
better
patient
ventil
synchroni
airway
pressur
releas
ventil
pressurelimit
timecycl
mode
partial
ventilatori
support
allow
unrestrict
spontan
breath
entir
ventilatori
cycl
permit
diaphragmat
contract
suggest
might
reduc
depend
atelectasi
howev
signific
evid
demonstr
lung
overdistent
occur
pressurepreset
modal
even
plateau
airway
pressur
remain
cm
h
pressurepreset
mode
ventil
chosen
imper
ensur
exhal
tidal
volum
exceed
current
guidelin
critic
ill
often
wateravid
state
retrospect
studi
posit
fluid
balanc
associ
advers
clinic
outcom
prospect
random
control
clinic
trial
ardsnet
investig
show
use
restrict
fluid
manag
strategi
improv
lung
function
increas
number
ventilatorand
intens
care
unit
icu
free
day
furthermor
conserv
fluid
manag
increas
incid
shock
need
dialysi
basi
larg
wellconduct
studi
restrict
fluid
strategi
recommend
hemodynam
stabl
patient
aliard
salvag
therapi
techniqu
may
consid
patient
ard
critic
refractori
hypoxemia
mechan
ventil
prone
posit
lead
improv
ga
exchang
patient
prone
ventil
believ
benefit
patient
ard
elimin
depend
atelectasi
perhap
reduc
mechan
compress
lung
heart
potenti
mechan
action
includ
redistribut
blood
flow
high
ventilationperfus
area
improv
homogen
transpulmonari
pressur
administr
improv
respiratori
mechan
enhanc
secret
clearanc
although
techniqu
improv
oxygen
seem
surviv
benefit
addit
laborintens
techniqu
particularli
difficult
implement
obes
patient
prone
develop
sever
ard
caus
highfrequ
oscillatori
ventil
provid
alveolar
ventil
small
tidal
volum
ml
thu
theoret
may
provid
optimum
lung
protect
ventilatorinduc
lung
injuri
anim
studi
inde
shown
highfrequ
oscillatori
ventil
may
attenu
ventilatorinduc
lung
injuri
howev
avail
human
data
demonstr
surviv
benefit
ard
techniqu
requir
special
expertis
advoc
routin
use
time
nitric
oxid
potent
endogen
vasodil
exogen
administ
inhal
reduc
intrapulmonari
shunt
physiolog
dead
space
vasodil
pulmonari
arteriol
wellventil
unit
although
inhal
may
result
transient
improv
oxygen
improv
translat
surviv
benefit
addit
patient
receiv
may
increas
risk
renal
insuffici
extracorpor
membran
oxygen
ecmo
wide
accept
rescu
modal
neonatolog
pediatr
narula
et
al
role
adult
ard
remain
controversi
sever
case
seri
document
good
clinic
outcom
associ
use
ecmo
recent
australia
new
zealand
ecmo
influenza
investig
report
excel
outcom
seri
patient
ard
howev
date
prospect
random
clinic
trial
report
first
zapol
et
al
demonstr
surviv
benefit
cohort
patient
variou
caus
acut
respiratori
failur
recent
peek
et
al
report
result
unit
kingdom
nation
health
servic
trial
cesar
trial
studi
random
adult
sever
ard
receiv
either
convent
mechan
ventil
commun
hospit
ecmo
tertiari
referr
center
intenttotreat
analysi
demonstr
better
clinic
outcom
group
refer
ecmo
among
patient
refer
ecmo
actual
receiv
ecmo
mortal
howev
among
patient
refer
ecmo
receiv
lungprotect
mechan
ventil
instead
mortal
even
lower
summari
avail
data
provid
compel
rational
use
ecmo
sever
ard
time
rational
use
glucocorticoid
ard
found
fact
broad
antiinflammatori
antifibrot
effect
prospect
random
crossov
trial
patient
sever
earli
ard
suggest
methylprednisolon
infus
mgkgd
reduc
lung
injuri
score
multipl
organ
dysfunct
syndrom
score
durat
mechan
ventil
icu
mortal
furthermor
treat
patient
lower
rate
secondari
bacteri
infect
unfortun
studi
limit
crossov
design
use
steroid
rescu
therapi
late
cours
ard
investig
patient
anoth
random
control
trial
call
late
steroid
rescu
studi
steroid
show
surviv
benefit
treatment
initi
day
onset
ard
although
observ
studi
patient
ali
caus
report
good
clinic
outcom
combin
oseltamivir
methylprednisolon
control
data
lack
basi
failur
steroid
benefit
patient
ard
caus
viral
etiolog
sever
acut
respiratori
syndrom
hantaviru
respiratori
syncyti
viru
data
fail
produc
convinc
argument
use
ard
summari
increas
clinic
suspicion
influenza
earli
initi
appropri
antimicrobi
therapi
knowledg
optim
icu
support
modal
necessari
skill
set
physician
care
patient
potenti
aliard
